On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.
Neurogenetics

Congenital insensitivity to pain (SCN9A)

This condition means individuals cannot experience physical pain, temperature extremes, or pressure. It typically presents from birth and can lead to unnoticed injuries, often affecting bone health and increasing the risk of infection.

Autosomal recessive Neurogenetics OMIM:243000
Very rare
Prevalence
Population estimate
25%
Inheritance
Autosomal recessive - if both parents are carriers, each child has a 25% chance of being affected; a carrier passes the variant on 50% of the time
1
Associated genes
SCN9A

Available at Jeen Health

Clinical tests that include this

Overview

Congenital insensitivity to pain due to changes in SCN9A (CIP-SCN9A) is a very rare inherited disorder where individuals are unable to perceive physical pain. This means they do not feel things like cuts, burns, or broken bones, and may also have a reduced ability to sense extreme temperatures or deep pressure [PMID:28794821]. This condition is present from birth, and because pain is a vital warning signal, individuals with CIP-SCN9A are at a high risk of recurrent injuries, fractures, and infections that might otherwise go unnoticed.

The inability to feel pain can lead to significant health challenges, particularly during childhood, as individuals may not be aware of harm occurring to their body. Repeated injuries, especially to joints and bones, can cause cumulative damage over time, affecting mobility and quality of life. The exact prevalence of CIP-SCN9A is not well established, but it is considered extremely rare.

Symptoms & clinical features

Individuals with congenital insensitivity to pain (SCN9A) primarily present with a complete or near-complete absence of pain perception. This typically becomes apparent in infancy or early childhood when unexplained injuries are observed. Common symptoms include frequent unnoticed burns, cuts, and bruises, as well as fractures that often go undiagnosed until complications arise [PMID:28794821].

Repeated head injuries, dental damage, and joint problems are frequently seen. Bone and joint deformities can develop due to repeated mild trauma that would normally cause pain signals in unaffected individuals. In some cases, individuals may also have a reduced sense of smell (anosmia) [PMID:16507490]. Developmental milestones are generally unaffected, and cognitive abilities are typically normal.

Video: Genetics 101

Affected organs

The primary impact of congenital insensitivity to pain (SCN9A) is on the nervous system, specifically the pain pathways, though the lack of pain sensation secondarily affects multiple organ systems. The peripheral nervous system, which transmits pain signals to the brain, is unable to function correctly. This leads to a cascade of effects throughout the body.

Bone and joint health are significantly affected due to repetitive, unnoticed trauma, leading to recurrent fractures, dislocations, and degenerative joint disease (arthropathy). The skin is also vulnerable to burns, cuts, and infections, as injuries may not be felt. Dental issues, including tooth loss and jaw damage, are common due to biting the tongue or cheek and not feeling dental pain.

Brain
Brain
Central nervous system involvement
Cellular impact
Cellular impact
Mechanism at cellular level

Risks & severity

Congenital insensitivity to pain (SCN9A) carries significant lifetime risks due to the absence of pain perception. The severity of the condition usually involves a complete inability to feel pain from birth. This leads to a high cumulative risk of tissue damage, bone fractures, and infections. Early recognition and careful management are crucial to mitigate these risks.

Repeated injuries can lead to severe joint damage, particularly in load-bearing joints, and increase the likelihood of chronic infections (e.g., osteomyelitis) because injuries or infections are not detected promptly. Without the protective mechanism of pain, affected individuals face life-threatening risks, including severe accidents and undiagnosed internal injuries or medical emergencies. Education for the individual and their family on injury prevention and constant vigilance is essential to manage these serious risks.

Genetic causes

Congenital insensitivity to pain (SCN9A) is caused by pathogenic variants in the SCN9A gene. This gene provides instructions for making one part (the alpha subunit) of a sodium channel called Nav1.7 [PMID:16107934]. These Nav1.7 channels are found primarily in nerve cells called nociceptors, which are specialised to detect painful stimuli like extreme temperatures, pressure, or chemical irritants.

Normally, when nociceptors are stimulated, the Nav1.7 channels open, allowing sodium ions to flow into the cell. This creates an electrical signal that travels along the nerve to the brain, where it is interpreted as pain. Pathogenic variants in SCN9A typically lead to a non-functional or significantly impaired Nav1.7 channel. This prevents the generation and transmission of pain signals, resulting in congenital insensitivity to pain. This is different from other conditions where overactive Nav1.7 channels cause severe pain syndromes.

  • SCN9A
    sodium voltage-gated channel alpha subunit 9
    The SCN9A gene provides instructions for a key component of the NaV1.7 sodium channel, vital for transmitting electrical signals in nerve cells, particularly those involved in pain sensation.

Inheritance pattern

Congenital insensitivity to pain (SCN9A) is inherited in an autosomal recessive pattern. This means that a person must inherit two altered copies of the SCN9A gene - one from each parent - to have the condition.

Individuals who inherit only one altered copy of the SCN9A gene are called carriers. Carriers typically do not show any symptoms of the condition because their other, working copy of the gene can compensate. When two carriers have children, there is a 25% chance with each pregnancy for the child to inherit two altered copies and develop the condition, a 50% chance for the child to be a carrier, and a 25% chance for the child to inherit two working copies and not be a carrier.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Diagnosis & testing

Diagnosing congenital insensitivity to pain (SCN9A) usually begins with clinical observations, such as repeated unexplained injuries or a child showing no reaction to typically painful stimuli. A definitive diagnosis is confirmed through genetic testing, specifically looking for pathogenic variants in the SCN9A gene. This testing can be initiated by a clinical geneticist or neurologist.

Referral for genetic testing within the NHS is typically made through a regional clinical genetics service. This service can request testing under an appropriate R-code, facilitating the identification of the underlying genetic cause. Genetic counsellors play a key role in explaining the testing process, interpreting results, and discussing implications for the individual and their family.

Management & lifestyle

Due to the lack of pain as a protective mechanism, management for congenital insensitivity to pain (SCN9A) focuses primarily on injury prevention, frequent monitoring for unnoticed injuries, and addressing any complications that arise. There is no specific cure, so care is supportive and multidisciplinary. Families and caregivers require extensive education on how to protect the affected individual from harm.

Regular medical check-ups are essential to screen for fractures, infections, and joint issues that might otherwise go undetected. This may involve imaging studies. Orthopaedic management is often needed for bone and joint problems. Dental care is also a priority to address oral injuries. Genetic counselling is important for affected individuals and their families to understand the condition, its inheritance, and implications for family planning, linking into the NHS Genomic Medicine Service where appropriate.

UK care pathway

Within the UK, individuals with suspected inherited conditions like congenital insensitivity to pain (SCN9A) are typically referred by their GP or specialist to a regional Clinical Genetics Service. These services are part of the NHS Genomic Medicine Service and facilitate diagnostic genetic testing, which is often carried out under specific R-codes for rare disease diagnosis. Genetic counsellors are integral to these services, providing information, support, and guidance on the condition, its inheritance, and the implications for the wider family. They also help navigate the complex information involved in genomic testing and results.

Frequently asked questions

Can someone with CIP-SCN9A feel anything at all?

Yes, individuals with CIP-SCN9A can still feel touch, pressure, and vibrations. Their ability to sense temperature might also be reduced, but they typically retain other sensations, as the condition specifically affects pain perception.

What are the biggest dangers for someone with this condition?

The main risks are severe injuries, such as unnoticed fractures, burns, or deep cuts, and infections that go undetected. Because pain acts as a warning signal, the absence of it means injuries can become very serious before they are noticed and treated.

Is there a cure for congenital insensitivity to pain?

Currently, there is no cure for congenital insensitivity to pain (SCN9A). Management focuses on preventing injuries, closely monitoring for damage, and treating complications as they arise to improve quality of life and reduce health risks.

How is this condition inherited in a family?

Congenital insensitivity to pain (SCN9A) is passed down in an autosomal recessive manner. This means a child must inherit two altered copies of the SCN9A gene, one from each parent, to develop the condition. Parents who each carry one altered copy typically show no symptoms themselves.

Is life expectancy affected by congenital insensitivity to pain?

While the condition itself does not directly affect fundamental bodily functions, the increased risk of severe, unnoticed injuries and infections can potentially reduce life expectancy if not managed extremely carefully. Good management and close monitoring are key to improving outcomes.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor.